Cargando…
Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200
In the ontogeny of a normal immune response, a series of checkpoints must be overcome to ensure that unwanted and/or harmful self-directed activation responses are avoided. Many of the molecules now known to be active in this overseeing of the evolving immune activation cascade, contributing inhibit...
Autores principales: | Gorczynski, Reginald M, Zhu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691938/ https://www.ncbi.nlm.nih.gov/pubmed/29180896 http://dx.doi.org/10.2147/CMAR.S147326 |
Ejemplares similares
-
Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling
por: Gorczynski, Reginald M., et al.
Publicado: (2013) -
Characterization of CD200 Ectodomain Shedding
por: Wong, Karrie K., et al.
Publicado: (2016) -
Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model
por: Curry, Anna, et al.
Publicado: (2017) -
Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis
por: Chen, Zhiqi, et al.
Publicado: (2016) -
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)